IL10 and neoplasm: Within the tumour microenvironment (TME), IL-35 and IL-10 work synergistically to drive T cell exhaustion by regulating inhibitory receptor expression and shaping exhaustion-associated transcriptomic profiles of CD8+ tumour-infiltrating lymphocytes (TILs) (34).